Page 3 - Annual Enteritis Prevention Program - CLOSTAT 365

IMPACT OF NECROTIC ENTERITIS

Incidences of enteritis throughout year
Economic Loss
& Loss due to sub-clinical & clinical cases
Psychological
pressure
High cost due to increased dose of AGP & medication

Damaged brand reputation for commercial feed manufacturers

SURPRISING TRUTH OF COMMONLY USED AGPs & PROBIOTICS

In vitro study on field strains of Clostridium perfringens
TM
It showed the efficacy of CLOSTAT against AGPs, and other probiotics.
Available solutions for Necrotic Enteritis has shown different responses against field strains.

100%
90%
83% 78% 83%
Zone of Performance (mm) 14.3 12.9 12.2 72% 15.6 58% 63% 71% 12.8

11.2
11
9.8
9

Enramycin Enramycin BMD BMD CLOSTAT TM Lactic acid Other Bacillus Other
(Double Dose) (Recommended (Double Dose) (Recommended (Recommended bacteria- Bacillus subtilis Multistrain Bacillus subtilis
Dose) Dose) Dose) Multistrain Product A + Saccharomyces Product B
Ref: Kemin Internal Source- TL-19-17410
As a leader in Gut Health, we are responsible for finding the better than the best

solution for 365 Days of Better Gut Health & Peace of Mind .

365 Days of 365 Days of
Healthy Gut Peace of Mind
Seasonal high
Cost of usage than
alternates Unreliable recommended dose
alternatives
Inconsistent
results
Water
medication